IDEXX Laboratories, Inc.
IDEXX develops and distributes products for companion animal veterinary, livestock, poultry, dairy, and water testing markets globally. The company operates through three segments: Companion Animal Group, Water Quality Products, and Livestock, Poultry, and Dairy. It offers point-of-care diagnostic products, reference laboratory services, and practice management systems for veterinarians. IDEXX also provides diagnostic products for livestock, poultry, and dairy, as well as water testing products. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. Products are marketed through various channels, including marketing, customer service, sales, and technical service groups.
Overview
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): consistently high returns on capital, returns well above its cost of capital, an asset-light, cash-generative model, high, stable gross margins (pricing power) and operating margins that held up every year.
- Return on invested capital has stayed above 15% in each of the last 6 years (latest 48.2%), a hallmark of a durable competitive advantage.
- Creates economic value: ROIC of 48.2% against a cost of capital (WACC) of 9.4%, a spread of 38.7 percentage points.
- Pricing power: gross margin has held between 58% and 62% over the last 6 years (latest 61.8%).
- Asset-light, cash-generative model: capital expenditure takes only 3.7% of revenue and free cash flow was positive in each of the last 6 years.
- Predictable earnings: earnings per share have grown along a steady trend of 12.7% a year.
Weaknesses
- Our discounted cash flow target price (288.56 USD) is 57% below the current price.
- Valued at a premium to its Diagnostics & Research peers: P/E 50.5x vs. a median of 31.4x, P/FCF 51.2x vs. a median of 24.1x and EV/EBITDA 35.9x vs. a median of 15.5x.
Key Financial Data